Publicaciones en las que colabora con José María Sayagues Manzano (25)

2023

  1. The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients

    Diagnostics, Vol. 13, Núm. 14

2021

  1. Genomic profiling of sporadic liver metastatic colorectal cancer

    Seminars in Cancer Biology, Vol. 71, pp. 98-108

  2. Tracking the antibody immunome in sporadic colorectal cancer by using antigen self-assembled protein arrays

    Cancers, Vol. 13, Núm. 11

2020

  1. Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients

    Oncotarget, Vol. 9, Núm. 35, pp. 24081-24096

  2. Development and results of a novel pancreas transplant program in Spain: the surgeon's point of view

    Cirugia Espanola, Vol. 96, Núm. 4, pp. 205-212

  3. Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients after Pancreaticoduodenectomy

    Journal of Clinical Gastroenterology, Vol. 52, Núm. 2, pp. e11-e17

  4. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: A mutational-based approach

    Oncotarget, Vol. 9, Núm. 76, pp. 34279-34288

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

2015

  1. Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas

    Oncotarget, Vol. 6, Núm. 22, pp. 19070-19086

2014

  1. Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

    Journal of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 648-659

  2. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer

    Medicine (United States), Vol. 93, Núm. 26

  3. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer

    Cancer, Vol. 120, Núm. 13, pp. 1948-1959

  4. Improving the outcome of acute cholecystitis: the non-standardized treatment must no longer be employed

    Langenbeck's Archives of Surgery, Vol. 399, Núm. 8, pp. 1065-1070

2012

  1. Identificación de biomarcadores en cáncer colorrectal mediante NAPPA arrays. Implicaciones en la respuesta al tratamiento con radioquimioterapia preoperatoria

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 95-95

  2. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays

    Modern Pathology, Vol. 25, Núm. 4, pp. 590-601

2011

  1. Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 K SNP-arrays and tumor histopathology

    PLoS ONE, Vol. 6, Núm. 7

  2. Cytogenetic heterogeneity of pancreatic ductal adenocarcinomas: Identification of intratumoral pathways of clonal evolution

    Histopathology

  3. Translational biomarker: identification of biomarkers related to capecitabine response in solid tumors by nucleic acids programmable protein microarrays (NAPPA), antibody arrays, IFISH and SNPS approaches

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 7, pp. 201-201